-
Metabolomics Market by Application (Nutrigenomics, Biomarker & Drug Discovery, Toxicology), Product (NMR, Mass Spectrometry, GC, HPLC, UPLC, Bioinformatics, Surface based mass analysis), Indication (Inborn Errors, Oncology, Cardiology) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 22, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Molecular Biology Enzymes and Kits & Reagents Market by End User (Hospitals & Diagnostic Centers, Academic & Research Institutes), Product (Enzymes, Kits & Reagents), Application (Sequencing, Cloning, PCR, Epigenetics), and Region – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 22, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Electrophoresis Reagents Market by Product (Dyes (EtBr & SYBR) Gels (Starch, Polyacrylamide, & Agarose) Buffer (TAE & TBE)) by Application (DNA & RNA Analysis, Protein Analysis) by Technique (Capillary & Gel Electrophoresis) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 22, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Research Antibodies Market by Technology (Elisa, Western Blot, Flow Cytometry, Immunohistochemistry), Product (Antibodies, Reagents), Application, & End User – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 22, 2023Select options This product has multiple variants. The options may be chosen on the product page -
HLA Typing for Transplant Market by Application (Research, Diagnostics), Technology (NGS, SSO-PCR, SSP-PCR, Sanger’s Sequencing), Products & Services (Software, Instruments, Reagents), End User (Diagnostic Center) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 22, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Microbiome Sequencing Services Market by Laboratory Type (Dry Lab, Wet Lab), Technology (Sequencing by Synthesis), Application (RNA Sequencing), Research Type (Outsourcing), End User (Pharmaceutical & Biotechnology), Other Technologies – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 22, 2023Select options This product has multiple variants. The options may be chosen on the product page -
In-Vitro Toxicology/Toxicity Testing Market by Industry (Cosmetics, Pharmaceutical), Product & Services, Toxicity Endpoint & Test (Dermal Toxicity, Carcinogenicity), Method (Cellular Assays), Technology (HTS, Cell-based), Region-2024 to 2029
$3,850.00 – $5,850.00Published on: January 22, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Membrane Chromatography Market by Product (Syringe Filter, Consumable (Capsule/Cartridge, Membrane Filter, Spin Column), Accessories), Hydrophobic Interaction), Technique (Affinity (Anion, Ion exchange), Operation mode (Flow through) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 22, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Collagen & Gelatin Market for Regenerative Medicine (by Source (Porcine, Bovine, Marine), Value and Volume Analysis, Application (Orthopedic, Wound Care, Cardiovascular)) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Environmental Monitoring Market by Sampling Method (Active, Continuous), Product (Sensors, Wearables, Indoor, Outdoor Monitors), Component (Temperature, Noise, Particulate, Gas), Application – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Oligonucleotide Synthesis Market by End User (Pharmaceutical, Hospital, Biotechnology), by Product (Drugs, Probe, Linkers, Adaptor, Equipment, Reagent), Type, Application (Research, PCR, DNA, RNAi, Therapeutic) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Single use Bioreactors Market by Product, Type of Molecule, Type of Cell, Type, Application, End User – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region – Global Forecast 2024 – 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Stem Cell Assay Market by Product & Service (Kits, Instruments), Type (Purification, Viability, Identification), Cell Type (HSCs, Mesenchymal, iPSCs, hESCs), Application (Clinical Research, Regenerative Medicine), End User – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Cell Dissociation Market by Product (Enzymatic (Trypsin, Collagenase, Elastase) Non-enzymatic, DNase), Type (Tissue Dissociation), Tissue (Epithelial, Connective), End User (Research Institutes, Pharmaceutical) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Sterility Testing Market by Application (Medical Devices, Pharmaceutical & Biotechnology), Product (Kits and Reagents, Instruments, Services), Test (Direct Inoculation Sterility Testing, Membrane Filtration Sterility Testing) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Efficacy Testing Market by Product and Service (Services, Consumables), Application (Cosmetic & Personal Care Products, Pharmaceutical Manufacturing), Type (Disinfectant Efficacy Testing, Antimicrobial Efficacy Testing) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Injectable Drug Delivery Market by Patient Care Setting (Hospital, Home Care), Type (Formulation, Device), Therapeutic, Usage Pattern, Administration (Skin, Musculoskeletal), Immunization, Distribution Channel – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Cell Counting Market by Product (Instruments (Cell Counter, Spectrophotometer, Flow Cytometer, Hemocytometer, Hematology Analyzer), Consumables (Assay Kits, Reagent, Microplate)), End User (Hospital, Pharmaceutical, Research) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 21, 2023Select options This product has multiple variants. The options may be chosen on the product page
The Biotechnology Industry is witnessing an increase in collaborative partnerships with a view to developing newer techniques. During its “green wave” period the industry produced a number of agricultural applications. During its “red wave”, there were a number of developments in the medical space to target disease prevention and management. In its “white wave”, industrial applications were at the forefront. A further rise in demand for therapeutics and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is expected to further fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact rendering growth driver. It is expected to encourage researchers and manufacturers to increase R&D initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalised medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.
Our reports provide application insights, technology insights, regional insights and competitive insights on biomaterials, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology. To know more about our offerings in the Biotechnology market analysis, contact us.
The Biotechnology Industry is witnessing an increase in collaborative partnerships with the primary view of developing newer and pathbreaking technology. The market is set to expand at 9.9 percent CAGR to hit USD 775 billion by 2024 mainly on account of increase in the incidence of chronic diseases such as diabetes and cancer, development of technology innovation and favorable government conditions. The ratio of chronic disease all around the globe is continuously increasing, which is analyzed to propel growth in the industry overall. According to recent data, the estimated number of people affected by the chronic disease will rise to 629 million by 2045. Approximately half of America’s population suffers from at least one chronic disease and this number is growing continuously. These statistics are expected to pave the way for opportunities in the biotechnology market.
The industry has experienced what is known as a ‘wave’ phenomenon. During its ‘green wave’ period the industry produced a number of agricultural applications. During its ‘red wave’, there were a number of developments in the medical space to target disease prevention and management. In its ‘white wave’, industrial applications were at the forefront. A further rise in demand for therapeutic and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is also expected to boost fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact-rendering growth driver. It is expected to encourage researchers and manufacturers to increase research and development initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalized medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.
Global Market Studies’ Biotechnology Market Research reports analysis provide application insights, technology insights, regional insights and competitive insights vis-a-vis the subsectors of biomaterials, biomanufacturing, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology, among others. Key competitor analysis includes that of Agilent Technologies, Amgen, Abbott Laboratories, Bio-Rad Laboratories, BioGen Medical Instruments, Danaher, Merck, F. Hoffmann-La Roche, Illumina, PerkinElmer, Thermo Fisher Scientific and Qiagen.
Contact us at Global Market Studies to know more about our offerings in the Biotechnology sector.